HeyJaredSanket Koul
- Indexed articles, last 90 days
- 7
- Latest publication
- Sep 28, 2026
- Outlet visibility, for Rediff
- Top 50K sites
- Earliest in this view
- Jul 11, 2026
Latest articles
Premium Office Rents Surge in Mumbai, Delhi-NCR Due to Supply Constraints (opens the original)
Read excerpt
Office rents in key micro-markets of Mumbai and Delhi-NCR are witnessing a significant premium, driven by a persistent shortage of quality Grade-A commercial space and robust occupier demand across diverse sectors. Large office leases in Mumbai and Delhi-National Capital Region (NCR) are fetching premium rentals at key micro-locations, even as rents vary significantly across different areas. Consultants attribute the premium to constraints in quality Grade-A space and sustained occupier demand.
Fortis Healthcare moves Supreme Court against Delhi HC forensic audit order (opens the original)
Read excerpt
Fortis Healthcare has escalated its legal battle to the Supreme Court, challenging a Delhi High Court order for a forensic audit into alleged asset erosion by its former promoters, Malvinder and Shivinder Singh, amidst ongoing enforcement proceedings by Japanese drugmaker Daiichi Sankyo. Hospital chain Fortis Healthcare has moved the Supreme Court against a Delhi high court order directing a forensic audit into the alleged erosion of assets by its former promoters, brothers Malvinder and Shivind
Lupin eyes $500 million from biosimilars, expands global footprint (opens the original)
Read excerpt
Pharma giant Lupin is strategically expanding its biosimilar portfolio and global market presence, targeting a significant $500 million turnover from this segment within the next five years, alongside investments in manufacturing and a flexible commercialisation approach. Pharma major Lupin is stepping up its focus on biosimilars, with plans to expand its portfolio and presence across key global markets, executive director and global chief financial officer (CFO) Ramesh Swaminathan told Business
Hospitals Oppose Room Rate Cap (opens the original)
Read excerpt
'Indian private sector hospitals provide quality healthcare at a fraction of the global cost.' Healthcare industry stakeholders have raised concerns over the proposed capping of private hospital room rates at the average price of nearby three-star hotels, saying the move could make "quality healthcare financially unsustainable and undermine efforts to achieve better clinical outcomes". Early this month, a parliamentary committee on health recommended capping room charges at hospitals in major ci
H1N1, Flu Cases: 'No Need To Panic' (opens the original)
Read excerpt
Several Indian cities report a surge in influenza cases, prompting state governments to issue advisories asking people to mask up in public spaces and follow basic respiratory hygiene. Sales of anti-infectives and painkillers have risen this monsoon amid a rise in cases of Influenza A (H3N2) and Influenza A (H1N1), commonly known as swine flu, across several parts of the country. According to data from market research firm Pharmarack, anti-infective sales rose 6.15 per cent year-on-year (Y-o-Y)
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Rediff, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.